Archive
Quality Considerations: Redefining Test Systems from Animals to Tissues and Beyond
August 28, 2017The use of non-whole animal test methods transforms the way regulatory requirements are applied in preclinical testing. Recent global regulatory initiatives emphasize the importance of transitioning to human relevant assays and test systems that do not use animals. When these methods are moved from research into the regulated arena, GLP principles must be followed. The GLPs were originally written in the 1970s, when the vast majority of regulated research was performed using animals as the test system. Current innovative, alternative...
In Vitro Assessment of Skin Irritation Potential of Surfactant-based Formulations by Using a 3-D Skin Reconstructed Tissue Model and Cytokine Response
January 24, 2017The personal care industry is focused on developing safe, more efficacious, and increasingly milder products, that are routinely undergoing preclinical and clinical testing before becoming available for consumer use on skin. In vitro systems based on skin reconstructed equivalents are now established for the preclinical assessment of product irritation potential and as alternative testing methods to the classic Draize rabbit skin irritation test. We have used the 3-D EpiDerm™ model system to evaluate tissue viability and primary cytokine interleukin-1α release...
Video: The 3T3 Neutral Red Uptake Phototoxicity Test — Chinese
November 21, 2016This training video with Chinese subtitles explores a cell-based method for assessing Phototoxicity — or the potential for chemicals to cause damage after being exposed to light. The method is used widely around the world by many industries, including the cosmetics and pharmaceutical sectors. Disclaimer: Please note that the procedures shown in this video were for demonstration purposes only and that all assay procedures, except the UVA/dark exposure, should be performed in a biological safety cabinet using aseptic techniques. Due to...
Video: The 3T3 Neutral Red Uptake Phototoxicity Test — Portuguese
November 21, 2016This new training video with Portuguese subtitles explores a cell-based method for assessing Phototoxicity — or the potential for chemicals to cause damage after being exposed to light. The method is used widely around the world by many industries, including the cosmetics and pharmaceutical sectors. Disclaimer: Please note that the procedures shown in this video were for demonstration purposes only and that all assay procedures, except the UV A/dark exposure, should be performed in a biological safety cabinet using aseptic techniques....
Webinar: How GLPs Enhance the Quality of Regulated and Non-Regulated Toxicology
October 18, 2016This one-hour webinar, led by IIVS Director of Quality and Compliance, introduces some of the concepts of Good Laboratory Practices (GLPs) designed to promote study and data integrity within an in vitro toxicology framework. Applying these concepts within your own laboratory should aid in production of robust, repeatable studies. View Slides...
IIVS Announces Suite of Non-Animal Methods to Reduce Animal Testing for Skin Sensitization
September 6, 2016GAITHERSBURG, MD – September 6, 2016 – In response to a newly published OECD Test Guideline, IIVS announces the addition of the Human Cell Line Activation Test (h-CLAT, OECD TG 442E) to its suite of non-animal assays to determine skin sensitization. The assessment of skin sensitization has historically involved the use of laboratory animals; specifically guinea pigs and mice. In recent years, international research and validation efforts have paved the way for the use of non-animal methods. “Industry has provided the field...
3T3 Phototoxicity (OECD 432)
August 24, 2016The 3T3 Neutral Red Uptake (NRU) Phototoxicity assay is a 96-well cytotoxicity-based assay that utilizes BALB/c 3T3 mouse fibroblasts to measure the concentration-dependent reduction in neutral red uptake by the cells after exposure to a test material in the presence and absence of UVA light. Duplicate 96-well plates containing a monolayer of 3T3 cells are exposed to serial dilutions of a test material. One of the plates is exposed to 5 J/cm2 of UVA while the other plate is kept...
Direct Peptide Reactivity Assay (DPRA, OECD 442C)
August 24, 2016The DPRA (OECD 442C) is an in chemico assay that models the first key event in the skin sensitization Adverse Outcome Pathway (AOP) - skin, protein reactivity. Compounds implicated in causing Allergic Contact Dermatitis (ACD) are generally electrophilic in nature. This assay identifies dermal sensitizers based on their reactivity with synthetic peptides containing the nucleophilic amino acid residues lysine and cysteine. Using LC/UV, conjugation of the test material with the peptides can be analyzed. Trained by the developers of this assay (Procter & Gamble), IIVS...
Eye Irritation Test using Reconstructed Human Corneal Epithelium (RhCE) Models (EIT, OECD 492)
August 24, 2016The Eye Irritation Test (EIT) is an OECD-approved in vitro non-animal test method for identifying chemicals and mixtures that may be irritating to the corneal epithelium. The test method utilizes an in vitro reconstructed human corneal epithelium (RhCE) model (EpiOcular™, MatTek Corp. or HCE, SkinEthic™), in an acute exposure assay to support international regulatory labeling requirements, according to the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (UN GHS). The Eye Irritation Test can be used to support...
Fragrance & Flavors
August 24, 2016Exposure to fragrance chemicals is most commonly by direct skin contact. Allergic contact dermatitis (ACD) to fragrance ingredients is most often caused by cosmetic products, such as perfumes, deodorants, and aftershave products. Cosmetic fragrance ingredients should be assessed for exposure damage including skin sensitization (ACD), phototoxicity, skin irritation (irritant contact dermatitis), and respiratory irritation and sensitization. At IIVS, we have pre-clinical testing programs to address each of these endpoints to ensure the safety of fragrance ingredients.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...